Browsing: MedTech

Patients, providers and medtech firms submitted hundreds of comments to the Food and Drug Administration on how the agency should approach generative AI in medical devices.

ATLANTA, October 27 (Hypepotamus) –At the start of 2024, we wrote about how it was the year of the HealthTech and MedTech startup in Atlanta. Investment was flowing into companies, laboratories, and programs designed to help healthcare, life sciences, biotech, and medical device founders get their businesses off the ground.

More than 4,000 people across the medtech sector met in Boston for one of the industry’s biggest events of the year. Catch up on all the conference news in MedTech Dive’s roundup.

After a steady start to the year, biopharma and medtech capital markets saw selective momentum in the third quarter. In biopharma, public biotech market performance strengthened and IPO activity improved, while venture funding moderated. In medtech, M&A remained the most active channel, exceeding full-year 2025 deal value despite slower dealmaking in the third quarter.

ResMed CEO Mick Farrell, chair of AdvaMed’s board, said the group plans to come up with standards around privacy, cybersecurity and interoperability.

For the better part of a decade, the default advice handed to medtech founders planning a first-in-human (FIH) study fit in three words: go to Australia. The pitch was seductive and, for a while, mostly true. A notification-based regulatory pathway that could clear in weeks. A 43.5% refundable R&D tax offset. For a cash-constrained startup,…

Hospital leaders need more than promising medical devices. They need to understand how those tools will work together in the operating room — and how to prepare clinicians to use them.

The Paris-based life sciences VC company’s new fund Sofinnova MD Start IV represents a substantial increase from its predecessor,Sofinnova MD Start III, which closed at €63 million ($71 million). This growth trajectory underscores the expanding appetite for early-stage medtech innovation.

The venture capital firm expects to launch up to eight new medtech ventures over the next five years.

Attacks and Vulnerabilities Control device security Critical infrastructure Medical News SOC & Incident Response Supply Chain Security System Design & Architecture Threat Landscape Vulnerabilities